Your sector of activity
Genomics research
Clinical and Translational Research
Biopharma & CRO
Our Services
Genome, Exome, Panel
RNA Seq
Methylation
Methylation by sequencing
Methylation using Illumina MethEPIC
Sequencing Only
Genotyping
Nucleic Acid Isolation
Bioinformatics analysis
Tumor Genomic Analysis: Mercury
Gene Expression Analysis: Galileo
Advanced Genomic Analysis Service: GeCo
About us
Our History
Certifications
Board of Directors
Our Management Team
Job Offers
Communication
News
Events
Scientific Publications
Investors
Investor Relations
Annual General Meeting
Financial documents
Financial Communications
Archives
Financial Reports Archives
Archived Press Releases
Liquidity contract
Oncodna friendly takeover bid
Contact
Search
Back
Liquidity contract
Date
Liquidity account resources
News
Number of shares
Species
June 30, 2024
51 284
12.494,29 €
December 31, 2023
58 848
10.583,62 €
June 30, 2023
33 845
38 731 €
December 31, 2022
44 010
22 663,5 €
June 30, 2022
68 930
14 138,97 €
December 31, 2021
53 198
27 521,05 €
June 30, 2021
95 477
42 374,01 €
December 31, 2020
57 942
107 979,26 €
June 30, 2020
66 218
94 014,4 €
December 31, 2019
76 063
54 878,61 €
June 30, 2019
80 365
48 520,76 €
December 31, 2018
86 965
31 203,25 €
June 30, 2018
67 643
54 882,62 €
December 31, 2017
61 823
56 769,58 €
June 30, 2017
49 003
83 023,03 €
December 31, 2016
51 086
69 589,37 €
June 30, 2016
40 626
91 384,04 €
December 31, 2015
42 299
71 081,78 €
June 30, 2015
18 023
181 967,36 €
December 31, 2014
26 125
110 417,00 €
June 30, 2014
29 524
67 910,42 €
December 31, 2013
27 565
85 780,63 €
June 31, 2013
34 319
47 150,55 €
December 31, 2012
28 847
76 298,98 €
June 30, 2012
29 314
72 985,95 €
December 30, 2011
27 537
87 382,35 €
June 30, 2011
26 171
92 293,23 €
December 31, 2010
23 202
121 918,07 €